Type 2 Diabetes Medications: SGLT2 Inhibitors
|
|
- Clement Wilkinson
- 8 years ago
- Views:
Transcription
1 Type 2 Diabetes Medications: SGLT2 Inhibitors SGLT2 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? SGLT2 inhibitors is short for sodium glucose co-transporter 2 inhibitors Taken orally (by mouth) How do they work? Help to stop glucose from being taken in by the kidneys: the kidneys help to remove glucose from the blood. In people with type 2 diabetes, the kidneys can hold on to glucose, which can cause blood glucose levels to increase What are the benefits? Modest weight loss There is a low risk of hypoglycemia (blood glucose that is too low) with SGLT2 inhibitors. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures What are the side effects? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Most common: Yeast infections in men and women Urinary tract infection Increased need to urinate Stuffy or runny nose and sore throat There are two SGLT2 inhibitors approved by the U.S. Food and Drug Administration (FDA): Canagliflozin (INVOKANA ) Dapagliflozin (FARXIGA ) Also possible: Low blood pressure (hypotension) Kidney problems (renal impairment) Hypoglycemia if taken with a sulfonylurea or insulin High amounts of potassium in the blood (hyperkalemia; canagliflozin) Increased LDL-C (the bad cholesterol) Bladder cancer (dapagliflozin) Allergic reactions SGLT2 inhibitors are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O UR H E A LT H C A RE PR OV I D ER REFERENCES: FARXIGA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; Hasan FM, Alsahli M, Gerich JE. Diabetes Res Clin Pract. 2014;104(3): INVOKANA [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; Kim Y, Babu AR. Diabetes Metab Syndr Obes. 2012;5: MedlinePlus. Hypoglycemia. Available at: July 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.
2 Type 2 Diabetes Medications: DPP-4 Inhibitors DPP-4 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? DPP-4 inhibitors is short for dipeptidyl peptidase-4 inhibitors Taken orally (by mouth) How do they work? Help your pancreas to make more insulin: insulin helps to lower blood glucose Lower the amount of glucose made by your liver What are the benefits? DPP-4 inhibitors are weight neutral, meaning they do not cause weight gain There is a low risk of hypoglycemia (blood glucose that is too low) with DPP-4 inhibitors. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures What are the side effects? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Most common: Upper respiratory tract infection Stuffy or runny nose and sore throat Headache Upset stomach or diarrhea There are four DPP-4 inhibitors approved by the U.S. Food and Drug Administration (FDA): Alogliptin (NESINA) Linagliptin (TRADJENTA ) Saxagliptin (ONGLYZA ) Sitagliptin (JANUVIA ) Also possible: Inflammation of the pancreas (acute pancreatitis) Hypoglycemia if taken with a sulfonylurea or insulin Liver problems (alogliptin) Kidney problems (renal failure; sitagliptin) Allergic reactions DPP-4 inhibitors are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O U R H E A LT H C A RE PR OV I D ER REFERENCES: Brunton S. Int J Clin Pract. 2014;68: Davidson JA. Mayo Clinic Proc. 2010;85(12 suppl):s27-s37. Inzucchi SE, et al. Diabetes Care. 2012;35(6): JANUVIA [package insert]. Whitehouse Station, NJ: Merck & Co, Inc.; MedlinePlus. Hypoglycemia. Available at: NESINA [package insert]. Deerfield, IL: Takeda Pharmaceuticals America, Inc.; ONGLYZA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; TRADJENTA [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; June 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.
3 Type 2 Diabetes Medications: GLP-1 Receptor Agonists GLP-1 receptor agonists are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they given? Given as an injection: inserted into the fat under your skin GLP-1 receptor agonists is short for glucagon-like peptide-1 receptor agonists How do they work? Help your pancreas to make more insulin: insulin helps to lower blood glucose Lower the amount of glucose made by your liver Help to slow down the breakdown of your food: this slows down increases in blood glucose What are the benefits? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Modest weight loss May make you feel less hungry and more full There is a low risk of hypoglycemia (blood glucose that is too low) with GLP-1 receptor agonists. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures There are three GLP-1 receptor What are the side effects? agonists approved by the U.S. Most common: Food and Drug Administration Diarrhea (FDA): Nausea Reactions/itching at the injection site Exenatide (BYETTA ) Vomiting Exenatide extended release Headache (BYDUREON ) Indigestion Liraglutide (Victoza ) Constipation Also possible: Thyroid tumors, including cancer, were seen in rats and mice in studies during the medication testing process Inflammation of the pancreas (acute pancreatitis) Hypoglycemia if taken with a sulfonylurea or insulin Kidney problems (renal impairment) Allergic reactions GLP-1 receptor agonists are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O U R H E A LT H C A RE PR OV I D ER REFERENCES: Brunton S. Int J Clin Pract. 2014;68: BYDUREON [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; BYETTA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; Davidson JA. Mayo Clinic Proc. 2010;85(12 suppl):s27-s37. Inzucchi SE, et al. Diabetes Care. 2012;35(6): MedlinePlus. Hypoglycemia. Available at: Victoza [package insert]. Plainsboro, NJ: Novo Nordisk Inc.; June 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.
4 Medications Used to Treat Type 2 Diabetes This handout shows the different medications that your healthcare provider may prescribe to treat your type 2 diabetes, and where and how these medications work in your body to lower blood glucose. Type 2 diabetes medications are taken orally (by mouth), by injection (inserted into the fat under your skin), or inhaled (breathed in). Oral Injectable Amylin mimetic (pramlintide) Alpha-glucosidase inhibitors (acarbose, miglitol) Helps to decrease the amount of glucose made by your liver. Help to slow down the breakdown of starches (such as bread and potatoes) and certain types of sugar (such as table sugar) from your food in your intestines: this slows down increases in blood glucose. Helps to slow down the breakdown of foods in your stomach and intestines: this slows down increases in blood glucose GLP-1 receptor agonists (albiglutide, dulaglutide, exenatide, liraglutide) Help your pancreas to make more insulin: insulin helps to lower blood glucose Biguanide (metformin) Helps to decrease the amount of glucose made by your liver Helps to improve the way that insulin works in your muscles: if your muscles are more sensitive to insulin, it is easier for insulin to bring glucose from your blood into your muscles where glucose can be used for energy Help to decrease the amount of glucose made by your liver Helps to slow down the breakdown of foods in your stomach and intestines: this slows down increases in blood glucose DPP-4 inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin) Fat Tissue Help your pancreas to make more insulin: insulin helps to lower blood glusoce Insulins (aspart, detemir, glargine, glulisine, human, lispro) Replace the insulin made naturally by your body in your pancreas Help to decrease the amount of glucose made by your liver Dopamine receptor agonist (bromocriptine mesylate) The mechanism by which dopamine receptor agonists improve blood sugar is unknown Help to decrease the amount of glucose made by your liver Muscle Liver Help to move glucose from the bloodstream into your muscles and fat where glucose is used for energy Kidneys Some insulin is inhaled See pg. 2 Meglitinides (nateglinide, repaglinide) Help your pancreas to make more insulin: insulin helps to lower blod glucose Stomach SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin) Help to stop glucose from being reabsorbed into your kidneys. The kidneys help to remove glucose from your blood. In people with type 2 diabetes, the kidneys can hold on to glucose which can cause blood glucose levels to increase Sulfonylureas (glimepiride, glipizide, gliburide) Helps your pancreas to make more insulin: insulin helps to lower blood glucose Pancreas Intestines Descriptions are provided for informational purposes only. Consult full manufacturer s prescribing information for drug s uses, actions, and side by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual manufacturer s prescribing information for approved uses outside the United States. REFERENCES ADA. Other injectable medications. Available at: Thiazolidinediones (pioglitazone, rosiglitazone) Helps to decrease the amount of glucose made by your liver Help to improve the way that insulin works in your muscles and fat: if your muscles are more sensitive to insulin, it is easier for insulin to bring glucose from your blood into your muscles and fat where glucose can be used for energy FOR MOREhttp:// INFORMATION: T A LK W I T Hmedication/insulin/other-injectable-medications.html. Y O UR H E A LT H C A RE PR OV I D ER ADA. What are my options? Available at: Inzucchi SE, et al. Diabetes Care. 2012;35(6): Mayo Clinic. Diabetes treatment: medications for type 2 diabetes. Available at: Updated December 2014 For more information, talk to your healthcare provider This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.
5 Medications Used to Treat Type 2 Diabetes Oral Injectable Alpha-glucosidase inhibitors (acarbose, miglitol) Available as Glyset (miglitol); PRECOSE (acarbose) Amylin mimetic (pramlintide) Available as SYMLIN (pramlintide) Biguanide (metformin) Available as Fortamet, GLUCOPHAGE, GLUCOPHAGE XR, Glumetza, Riomet (metformin) ACTOplus met, ACTOplus met XR (pioglitazone and metformin); Avandamet (rosiglitazone and metformin); GLUCOVANCE (gliburide and metformin); Janumet, Janumet XR (metformin and sitagliptin); Jentadueto (linagliptin and metformin); KAZANO (alogliptin and metformin); KOMBIGLYZE XR (saxagliptin and metformin); METAGLIP (glipizide and metformin); PrandiMet (metformin and repaglinide); XIGDUO XR (dapagliflozin and metformin) Glucagon-like peptide-1 (GLP-1) receptor agonists (albiglutide, dulaglutide, exenatide, liraglutide) Available as BYDUREON (extended-release exenatide); BYETTA (regular exenatide); TANZEUM (albiglutide); TRULICITY (dulaglutide); Victoza (liraglutide) Dipeptidyl peptidase-4 (DPP-4) inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin) Available as Januvia (sitagliptin); NESINA (alogliptin); Onglyza (saxagliptin); Tradjenta (linagliptin) Janumet, Janumet XR (metformin and sitagliptin); Jentadueto (linagliptin and metformin); Juvisync (sitagliptin and simvastatin); KAZANO (alogliptin and metformin); KOMBIGLYZE XR (saxagliptin and metformin); OSENI (alogliptin and pioglitazon) Insulins (aspart, detemir, glargine, glulisine, human, lispro) Available as Apidra (glulisine); Humalog, Humalog Mix50/50, Humalog Mix75/25 (lispro); Humulin N, Humulin R, Humulin 70/30 (human); Lantus (glargine); Levemir (detemir); Novolin N, Novolin R, Novolin 70/30 (human); NovoLog, NovoLog Mix 70/30 (aspart) Dopamine receptor agonist (bromocriptine mesylate) Available as CYCLOSET Inhaled Meglitinides (nateglinide, repaglinide) Available as Prandin (repaglinide); Starlix (nateglinide) PrandiMet (metformin and repaglinide) Insulin (human) Available as AFREZZA (insulin human) Sodium-glucose co-transporter 2 (SGLT2) inhibitors (canagliflozin, dapagliflozin, empagliflozin) Availble as FARXIGA (dapagliflozin), INVOKANA (canagliflozin), Jardiance (empagliflozin) XIGDUO XR (dapagliflozin and metformin) Sulfonylureas (glimepiride, glipizide, gliburidae) Available as Amaryl (glimepiride); DiaBeta, Glynase PresTab, or Micronase (gliburide); Glucotrol, Glucotrol XL (glipizide) Avandaryl (glimepiride and rosiglitazone); duetact (pioglitazone and glimepiride); GLUCOVANCE (gliburide and metformin); METAGLIP (glipizide and metformin) Thiazolidinediones (pioglitazone, rosiglitazone) Available as ACTOS (pioglitazone); Avandia (rosiglitazone) ACTOplus met, ACTOplus met XR (pioglitazone and metformin); Avandamet (rosiglitazone and metformin); Avandaryl (rosiglitazone and glimepiride); duetact (pioglitazone and glimepiride); OSENI (alogliptine and pioglitazone) This list of medications is provided for informational purposes only. Talk with your healthcare provider before starting or stopping any medications. The medications discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual manufacturer s prescribing information for approved uses outside the United States. Updated December 2014 This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.
6
7 Medicamentos para el tratamiento de la diabetes tipo 2 Medicamentos para el tratamiento de la diabetes tipo 2 A continuación se indican los nombres de los medicamentos disponibles para la diabetes tipo 2. Orales Inhibidores de la alfa-glucosidasa (acarbosa, miglitol) Ejemplos: Glyset (miglitol); PRECOSE (acarbosa) Biguanida (metformina) Ejemplos: Fortamet, GLUCOPHAGE, GLUCOPHAGE XR, Glumetza, Riomet (metformina) ACTOplus met, ACTOplus met XR (pioglitazona y metformina); Avandamet (rosiglitazona y metformina); GLUCOVANCE (gliburida y metformina); Janumet, Janumet XR (metformina y sitagliptina); Jentadueto (linagliptina y metformina); KAZANO (alogliptina y metformina); KOMBIGLYZE XR (saxagliptina y metformina); METAGLIP (glipizida y metformina); PrandiMet (metformina y repaglinida) Inhibidores de la dipeptidil peptidasa-4 (DPP-4) (alogliptina, linagliptina, saxagliptina, sitagliptina) Ejemplos: Januvia (sitagliptina); NESINA (alogliptina); Onglyza (saxagliptina); Tradjenta (linagliptina) Janumet, Janumet XR (metformina y sitagliptina); Jentadueto (linagliptina y metformina); Juvisync (sitagliptina y simvastatina); KAZANO (alogliptina y metformina); KOMBIGLYZE XR (saxagliptina y metformina); OSENI (alogliptina y pioglitazona) Meglitinidas (nateglinida, repaglinida) Ejemplos: Prandin (repaglinida); Starlix (nateglinida) Producto combinado: PrandiMet (metformina y repaglinida) Inhibidores del cotransportador sodio-glucosa 2 (SGLT2) (canagliflozina, dapagliflozina) Ejemplos: FARXIGA (dapagliflozina), INVOKANA (canagliflozina) Sulfonilureas (glimepirida, glipizida, gliburida) Ejemplos: Amaryl (glimepirida); DiaBeta, Glynase PresTab, o Micronase (gliburida); Glucotrol, Glucotrol XL (glipizida) Avandaryl (glimepirida y rosiglitazona); duetact (pioglitazona y glimepirida); GLUCOVANCE (gliburida y metformina); METAGLIP (glipizida y metformina) Tiazolidindionas (pioglitazona, rosiglitazona) Ejemplos: ACTOS (pioglitazona); Avandia (rosiglitazona) ACTOplus met, ACTOplus met XR (pioglitazona y metformina); Avandamet (rosiglitazona y metformina); Avandaryl (rosiglitazona y glimepirida); duetact (pioglitazona y glimepirida); OSENI (alogliptina y pioglitazona) Mimético de la amilina (pramlintida) Ejemplo: SYMLIN (pramlintida) Inyectables Agonistas del receptor del péptido 1 análogo al glucagón (GLP-1) (exenatida, liraglutida) Ejemplos: BYETTA (exenatida corriente); BYDUREON (exenatida de liberación prolongada); Victoza (liraglutida) Insulinas (aspártica, detemir, glargina, glulisina, humana, lispro) Ejemplos: Apidra (glulisina); Humalog, Humalog Mix50/50, Humalog Mix75/25 (lispro); Humulin N, Humulin R, Humulin 70/30 (humana); Lantus (glargina); Levemir (detemir); Novolin N, Novolin R, Novolin 70/30 (humana); NovoLog, NovoLog Mix 70/30 (aspártica) Esta lista de medicamentos se ofrece únicamente con fines informativos. Consulte con su profesional de la salud antes de iniciar o suspender cualquier tratamiento con medicamentos. Los medicamentos descritos están aprobados para su uso en los Estados Unidos por la Administración de Alimentos y Medicamentos (FDA) a menos que se indique lo contrario. Consulte la información de prescripción de cada fabricante para saber los usos aprobados en el exterior de los Estados Unidos. Julio de 2014 Patrocinado por KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2014 KnowledgePoint360 Group, LLC. Reservados todos los derechos. El contenido de esta hoja fue creado por KnowledgePoint360 Group, LLC, y no estuvo asociado a ningún financiamiento a través de una subvención educativa o un interés publicitario o comercial.
DIABETES EDUCATION. *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS
DIABETES EDUCATION *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS ACTION: Sulfonylureas stimulate the pancreas to make more insulin (pancreas
More informationType 2 Diabetes Medicines: What You Need to Know
Type 2 Diabetes Medicines: What You Need to Know Managing diabetes is complex because many hormones and body processes are at work controlling blood sugar (glucose). Medicines for diabetes include oral
More informationMedicines Used to Treat Type 2 Diabetes
Goodman Diabetes Service Medicines Used to Treat Type 2 Diabetes People who have type 2 diabetes may need to take medicine to help lower their blood glucose, in addition to being active & choosing healthy
More informationNoninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause hypoglycemia MED GROUP DESCRIPTOR
Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause MED GROUP DESCRIPTOR INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) MICRONIZED GLYBURIDE*
More informationFYI: (Acceptable range for blood glucose usually 70-110 mg/dl. know your institutions policy.)
How Insulin Works: Each type of insulin has an onset, a peak, and a duration time. Onset is the length of time before insulin reaches the bloodstream and begins lowering blood Peak is the time during which
More information10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama
Faculty Medications for Diabetes Satellite Conference and Live Webcast Wednesday, November 7, 2012 2:00 4:00 p.m. Central Time Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University
More informationAcarbose INITIAL: 25 mg PO TID ($45) Miglitol INITIAL: 25 mg PO TID ($145)
PL Detail-Document #310601 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER June 2015 Drugs for Type 2
More informationTargeting the Kidney. Renal Glucose Transport 11/4/2015. Non insulin Agents Available IBITORS. Chao EC, et al. Nat Rev Drug Discovery. 2010;9:551 559.
SGLT-2i and DPP-IVi in the Management of Diabetes Mellitus Type 2 Abel Alfonso, D.O., F.A.C.E. Endocrinologist November 5, 2015 DIABETES: CURRENT RATES AND PROJECTIONS CDC Press Release 2010: 1 in 3 adults
More informationMedicines for Type 2 Diabetes A Review of the Research for Adults
Medicines for Type 2 Diabetes A Review of the Research for Adults Is This Information Right for Me? Yes, if: Your doctor or health care provider has told you that you have type 2 diabetes and have high
More informationHow To Treat Diabetes
Overview of Diabetes Medications Marie Frazzitta DNP, FNP c, CDE, MBA Senior Director of Disease Management North Shore LIJ Health Systems Normal Glucose Metabolism Insulin is produced by beta cells in
More informationApproximate Cost Reference List i for Antihyperglycemic Agents
Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4
More informationMary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes
Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Objectives Pathophysiology of Diabetes Acute & Chronic Complications Managing acute emergencies Case examples 11/24/2014 UWHealth
More informationWhat I need to know about. Diabetes Medicines. National Diabetes Information Clearinghouse
What I need to know about Diabetes Medicines National Diabetes Information Clearinghouse What I need to know about Diabetes Medicines Contents What do diabetes medicines do?... 1 What targets are recommended
More informationDiabetes Medications. Minal Patel, PharmD, BCPS
Diabetes Medications Minal Patel, PharmD, BCPS Objectives Examine advantages and disadvantages of oral anti-hyperglycemic medications Describe the differences between different classes of insulin Explore
More informationPharmaceutical Management of Diabetes Mellitus
1 Pharmaceutical Management of Diabetes Mellitus Diabetes Mellitus (cont d) Signs and symptoms 2 Elevated fasting blood glucose (higher than 126 mg/dl) or a hemoglobin A1C (A1C) level greater than or equal
More informationDiabetes Update Lanita S. Shaverd, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor, UAMS College of Pharmacy
Objectives Review oral medications used for the treatment of diabetes Explain how to effectively combine oral diabetes medications for optimal results Discuss insulins and non-insulin injectable diabetes
More informationFundamentals of Diabetes Care Module 5, Lesson 1
Module 5, Lesson 1 Fundamentals of Diabetes Care Module 5: Taking Medications Healthy Eating Being Active Monitoring Taking Medication Problem Solving Healthy Coping Reducing Risks Foundations For Control
More informationPills for Type 2 Diabetes. A Guide for Adults
Pills for Type 2 Diabetes A Guide for Adults December 2007 Fast Facts on Diabetes Pills n Different kinds of diabetes pills work in different ways to control blood sugar (blood glucose). n All the diabetes
More informationComparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians
Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between
More informationDiabetes Mellitus Pharmacology Review
Diabetes Mellitus Pharmacology Review Hien T. Nguyen, Pharm.D., BCPS Clinical Pharmacist Specialist AtlantiCare Regional Medical Center E-Mail: HienT.Nguyen@atlanticare.org Objectives 1. Review the epidemiology
More informationDiabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute
Diabetes Treatments: Options for Insulin Delivery Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes 21 million people in the U.S. have diabetes $132 billion each
More informationMedications for Type 2 Diabetes
Main Page Risk Factors Symptoms Diagnosis Treatment Screening Complications Reducing Your Risk Talking to Your Doctor Living With Type 2 Diabetes Resource Guide Medications for Type 2 Diabetes by Karen
More informationwe have to keep up. Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments
Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments Novo Nordisk Speaker/Consultant Speaker Fees/Honoraria Sanofi-Aventis Speaker/Consultant Speaker
More informationAdd: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above
Guidelines for Type Diabetes - Diagnosis Fasting Plasma Glucose (confirm results if borderline) HbAIC Normal FPG < 00 < 5.5 Impaired Fasting Glucose (IFG) 00 to < 5.7%-.5% Diabetes Mellitus (or random
More informationGuidelines for Type 2 Diabetes Diagnosis
Guidelines for Type 2 Diabetes Diagnosis Fasting Plasma Glucose (in asymptomatic individuals, repeat measurement to confirm the test) Normal FPG < 100 2-hr OGTT < 140 HbA1C < 5.5% Impaired Fasting Glucose
More informationDiabetes: Medications
Diabetes: Medications Presented by: APS Healthcare Southwestern PA Health Care Quality Unit (APS HCQU) May 2008 sh Disclaimer Information or education provided by the HCQU is not intended to replace medical
More informationMaking Clinical Sense of Diabetes Medications. Types of Diabetes. Pathophysiology. Beta Cell Function & Glucagon
Making Clinical Sense of Diabetes Medications Kathy Reily, RD, CDE Prince William Hospital Diabetes Program Coordinator Virginia Dietetic Association April 4, 2011 Types of Diabetes Type 1 DM = Beta Cell
More informationTREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13
TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS 1 Heather Healy, FNP-BC Martha Shelver, CS, ACNP-BC Saint Alphonsus Regional Medical Center 2 OBJECTIVES 3 Review the current management algorithms
More informationClass Update: Diabetes Medications. Month/Year of Review: September 2014 End date of literature search: August 2014
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationVolume 01, No. 08 November 2013
State of New Jersey Department of Human Services Division of Medical Assistance & Health Services New Jersey Drug Utilization Review Board Volume 01, No. 08 November 2013 TO: SUBJECT: PURPOSE: Physicians,
More informationMy Diabetes Care Plan
My Diabetes Care Plan You may use the charts below to help you better understand your diabetes. Ask your healthcare provider to review your goals and targets with you. Discuss the results and set up an
More informationOral Therapy for Type 2 Diabetes
Oral Therapy for Type 2 Diabetes Diabetes pills can help to manage your blood sugar. These pills are not insulin. They work to manage your blood sugar in several ways. You may be given a combination of
More informationAntidiabetic Drugs. Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Antidiabetic Drugs Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Diabetes Mellitus Two types Type 1 Type 2 Type 1 Diabetes Mellitus Lack of insulin production
More informationType 2 Diabetes Update For 2015
Type 2 Diabetes Update For 2015 Jerry Meece, RPh, CDE, FACA, FAADE Plaza Pharmacy and Wellness Center jmeece12@cooke.net Learning Objectives At the conclusion of this presentation, the participant will
More informationAnti-Diabetic Agents. Chapter. Charles Ruchalski, PharmD, BCPS. Drug Class: Biguanides. Introduction. Metformin
Chapter Anti-Diabetic Agents 2 Charles Ruchalski, PharmD, BCPS Drug Class: Biguanides The biguanide metformin is the drug of choice as initial therapy for a newly diagnosed patient with type 2 diabetes
More informationIt is estimated that 25.8 million people or 8.3% of the US
1.0 CPEUs and 2.0 ANCC Contact Hours An Overview of Glycemic Goals and Medications Used to Manage Type 2 Diabetes Mary-Kathleen Grams, PharmD Suzanne Dinsmore, PharmD, CGP Jennifer Goldman-Levine, PharmD,
More informationCara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,
More information4/23/2015. Conflict of Interest Disclosure
Endocrine/Diabetes Pharmacology Review May 8, 2015 Chris Winslow, PharmD, MBA and Amanda Brown, PharmD Conflict of Interest Disclosure A conflict of interest exists when an individual is in a position
More informationDiabetes Fundamentals
Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence
More informationNew and Emerging Diabetes Medications. What do Advanced Practice Nurses Need to Know? Lorraine Nowakowski-Grier,MSN,APRN,BC,CDE
New and Emerging Diabetes Medications What do Advanced Practice Nurses Need to Know? Lorraine Nowakowski-Grier,MSN,APRN,BC,CDE Objectives 1) Describe the clinical indications on select emerging novel diabetes
More informationDIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS
Section Two DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS This section will: Describe oral agents (pills) are specific for treating type 2 diabetes. Describe other hypoglycemic agents used
More informationMedications for Diabetes
AGS Diab Med Brochure 4/18/03 3:43 PM Page 1 Medications for Diabetes An Older Adult s Guide to Safe Use of Diabetes Medications THE AGS FOUNDATION FOR HEALTH IN AGING AGS Diab Med Brochure 4/18/03 3:43
More information6/22/2015. New medicines for type 2 diabetes when do you use them
New medicines for type 2 diabetes when do you use them 1. Oral Secretagogues (e.g. sulfonylureas) 2. Metformin 3. Alpha glucosidase inhibitors 4. Thiazolidinediones 5. GLP-1 receptor agonists 6. DPP-4
More informationMEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get
More informationLet s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014
Let s Talk About Meters and Meds Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 How to monitor diabetes control: Hemoglobin A 1 C, or just A 1
More informationThe prevalence of diabetes in the United States in
Medical Management of Type 2 Diabetes Celia Levesque, CNS-BC ABSTRACT More than 20 million Americans have type 2 diabetes. Managing blood glucose is an important component in delaying, slowing, or preventing
More informationChapter 4 Type 2 Diabetes
Chapter 4 Type 2 Diabetes (previously referred to as adult onset diabetes or non-insulin dependent diabetes) H. Peter Chase, MD Cindy Cain, RN, CDE Philip Zeitler, MD This is the most common type of diabetes
More informationTransitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens. Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015
Transitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015 Objectives 1) Describe and discuss some of the most common diabetes
More information25 mg QD-TID @ meals w/1st bite of. food, titrate Q 4 8 weeks; adjust based on 1 postprandial glucose; 100 mg TID max
Table Selected Non-Insulin Antihyperglycemic Agents Class Drug (Brand) Dosing Comments -Glucosidase inhibitors Acarbose a (Precose) 25 mg QD-TID @ meals w/1st bite of MOA: Enzyme inhibitor, delays hydrolysis
More informationDiabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?
What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin
More informationAntidiabetic Agents. Chapter. Biguanides
ajt/shutterstock, Inc. Chapter 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS Biguanides Introduction For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice
More informationDrug Class Review. Newer Diabetes Medications and Combinations
Drug Class Review Newer Diabetes Medications and Combinations Final Streamlined Update 1 Report June 2014 The purpose of Drug Effectiveness Review Project reports is to make available information regarding
More informationTreatment of Type 2 Diabetes
Improving Patient Care through Evidence Treatment of Type 2 Diabetes This information is based on a comprehensive review of the evidence for best practices in the treatment of type 2 diabetes and is sponsored
More informationPrimary Care Type 2 Diabetes Update
Primary Care Type 2 Diabetes Update May 16, 2014 Presented by: Barb Risnes APRN, BC-ADM, CDE Objectives: Discuss strategies to address common type 2 diabetes patient management challenges Review new pharmacological
More informationTreating Type 2 Diabetes
The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................
More information2013 International Diabetes Center
Day to Day Management of Diabetes Part 1 Review of Diabetes and Therapies Diane Reader RD, CDE Manager, Diabetes Professional Training International Diabetes Center Overview of Diabetes lucose and Insulin
More informationTreating Type 2 Diabetes
The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Our Recommendations Six classes of oral medicines (and 12 individual drugs) are now available to help the 25.8
More informationStaying Healthy With Diabetes
Staying Healthy With Diabetes For: We care. We will listen. We can help. Table of Contents Table of Contents... 1 Staying Healthy with Diabetes... 2 About Diabetes... 3 Blood Glucose Testing at Home...
More informationUpdate on the management of Type 2 Diabetes
Update on the management of Type 2 Diabetes Mona Nasrallah M.D Assistant Professor, Endocrinology American University of Beirut 10 th Annual Family Medicine Conference October 14,2011 Global Prevalence
More informationClinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives
What s New in Diabetes Medications? Matthew Kostoff, PharmD, BCPS, BCACP Clinical Assistant Professor Clinical Pharmacy Specialist Wesley Family Medicine Residency Program Objectives Discuss new literature
More informationAntihyperglycemic Agents Comparison Chart
Parameter Metformin Sulfonylureas Meglitinides Glitazones (TZD s) Mechanism of Action Efficacy (A1c Reduction) Hepatic glucose output Peripheral glucose uptake by enhancing insulin action insulin secretion
More informationLibyan International Medical University www.limu.edu.ly PBL-III. ZuhirBodalal
Libyan International Medical University www.limu.edu.ly PBL-III ZuhirBodalal Disclaimer The following is a collection of medical information from multiple sources, both online and offline. It is to be
More informationmedications for type 2 diabetes
Talking diabetes No.25 Revised August 2010 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help control their blood glucose levels. Most of
More informationmedications for type 2 diabetes
Talking diabetes No.25 Revised 2012 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications
More informationMy Diabetes Care Plan
My Diabetes Care Plan You may use the charts below to help you better understand your diabetes. Ask your healthcare provider to review your goals and targets with you. Discuss the results and set up an
More informationHarmony Clinical Trial Medical Media Factsheet
Overview Harmony is the global Phase III clinical trial program for Tanzeum (albiglutide), a product developed by GSK for the treatment of type 2 diabetes. The comprehensive program comprised eight individual
More informationDiabetes Medications at the End of Life. Goals and Objectives. Diabetes. Type 2 Diabetes Mellitus. Types of Diabetes
Diabetes Medications at the End of Life Paul J. Schmidt Jr., R.Ph., M.S. Clinical Supervisor HospiScript Services pschmidt@hospiscript.com Goals and Objectives Describe the Current Impact of Diabetes Mellitus
More informationUVA OUTPATIENT SURGERY CENTER (OPSC) PREPARING FOR SURGERY HANDBOOK
Surgeon Name/PIC: Surgery Name: Surgery Date: Patient Label or Patient NAME Patient UVA MRN ARRIVAL TIME: (provided by OPSC nurse during phone call) UVA OUTPATIENT SURGERY CENTER (OPSC) PREPARING FOR SURGERY
More informationTreating Type 2 Diabetes: The Oral Diabetes Drugs. Comparing Effectiveness, Safety, and Price
Treating Type 2 Diabetes: The Oral Diabetes Drugs Comparing Effectiveness, Safety, and Price Our Recommendations Six types of oral medicines (and 11 individual drugs) are now available to help the 21 million
More informationNew Non-Insulin Therapies for Type 2 Diabetes Mellitus
New Non-Insulin Therapies for Type 2 Diabetes Mellitus Ally P.H. Prebtani Associate Professor of Medicine Internal Medicine, Endocrinology & Metabolism McMaster University Canada Disclosure Relationships
More informationHow To Help People With Diabetes
Diabetes Medications and Medication Management Christopher Lamer, PharmD, MHS, BCPS, CDE November 2013 Okay, great. Well, I want to say thank you very much for giving me the opportunity to present and
More informationType 2 diabetes Definition
Type 2 diabetes Definition Type 2 diabetes is a lifelong (chronic) disease in which there are high levels of sugar (glucose) in the blood. Type 2 diabetes is the most common form of diabetes. Causes Diabetes
More informationHypoglycemia. National Diabetes Information Clearinghouse
Hypoglycemia National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is hypoglycemia? Hypoglycemia, also called low blood glucose or
More informationDiabetes: Beyond the D50. Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems
Diabetes: Beyond the D50 Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems The EMS View of Diabetes Management BG low? Give some form of sugar. Hero! BG somewhere
More informationControversies in the Management of Patients with Type 2 Diabetes
The New England Comparative Effectiveness Public Advisory Council Public Meeting October 29, 2014 Controversies in the Management of Patients with Type 2 Diabetes Draft Report September 2014 Authored by:
More informationSUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS
SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS PURPOSE To establish a process that will enable Certified Diabetes Educators (CDE) and/or staff with Board Certification in Advanced Diabetes Management
More informationE-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com
David Bruyette, DVM, DACVIM VCA West Los Angeles Animal Hospital 1818 South Sepulveda Blvd Los Angeles, CA 90025 310-473-2951 (ext 226) E-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com
More informationDiabetes WHAT YOU NEED TO KNOW. What is Diabetes? Inside:
Diabetes WHAT YOU NEED TO KNOW What is Diabetes? Diabetes means that there is too much sugar in your blood. Too much sugar causes damage to the body. Diabetes happens when there is a problem with a hormone
More informationDiabetes Mellitus Type 2
Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates
More informationDiana G. Mercurio, RPh, CDE, CDOE, CVDOE October 9, 2015
Diana G. Mercurio, RPh, CDE, CDOE, CVDOE October 9, 2015 I do not have any significant financial relationships to disclose. Primary prevention: treatment of individuals with no history of stroke Secondary
More informationPremixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s
Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines
More informationOBJECTIVES MEDICATIONS TO TREAT DIABETES MELLITUS. History of Diabetes Care. Barriers To Normalizing BG 2/11/2014. Significant Developments in DM
MEDICATIONS TO TREAT DIABETES MELLITUS R. Keith Campbell*, RPh, FAADE, FASHP, CDE Distinguished Professor of Diabetes Care/Pharmacotherapy, Emeritus Washington State University College of Pharmacy *No
More informationType 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action
Aims and Objectives This session will outline the increasing complexities of diabetes care, and the factors that differentiate the combinations of therapy, allowing individualisation of diabetes treatment.
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist
More informationDrug Class Review Newer Diabetes Medications, TZDs, and Combinations
Drug Class Review Newer Diabetes Medications, TZDs, and Combinations Preliminary Scan Report #1 Update #1 February 2013 The purpose of reports is to make available information regarding the comparative
More informationManagement of Clients with Diabetes Mellitus
Management of Clients with Diabetes Mellitus Black, J.M. & Hawks, J.H. (2005) Chapters 47, (pp 1243-1288) 1288) Baptist Health School of Nursing NSG 4037: Adult Nursing III Carole Mackey, MNSc,, RN, PNP
More informationEndocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D
Endocrine Disorders Diabetes Meds Objectives Explain the action of the various types of insulin currently available Identify the relationship between insulin peak and risk for hypoglycemia Discuss rationale
More informationSaxagliptin (Onglyza) for type 2 diabetes
Saxagliptin (Onglyza) for type 2 diabetes This Medicine Update is for people who are taking, or thinking about taking, saxagliptin. Summary Saxagliptin (brand name Onglyza) is a tablet that can be used
More informationPrescribing for Diabetes. England 2005-06 to 2013-14
Prescribing for Diabetes England 2005-06 to 2013-14 Published 12 August 2014 We are the trusted national provider of high-quality information, data and IT systems for health and social care. www.hscic.gov.uk
More informationManagement of Type 2 Diabetes Mellitus
Diabetes Mellitus Guideline Team Team Leaders Connie J Standiford, MD General Internal Medicine Sandeep Vijan, MD General Internal Medicine Team Members Hae Mi Choe, PharmD College of Pharmacy R Van Harrison,
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES
MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Incretin Mimetic/Enhancer Hypoglycemics (formerly referred to as Other Hypoglycemics) A. Thresholds for Prior Authorization All prescriptions
More informationSecond- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief
Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief March 7, 2016 Session Objective: The objective of this workshop is to assess the value of undertaking comparative effectiveness
More informationUp to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White
Up to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White Objectives: What is New in Therapy How to select medications Disclosures:
More informationEffective pharmacological treatment regimens for diabetes usually require
Medications Used in Diabetes in Patients Presenting for Anesthesia By Gabrielle O Connor, M.D., M.Sc., CCD, MRCP, FACP Dr. Gabrielle O Connor, a board certified endocrinologist who graduated from University
More informationMANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY
MANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY AND THE ROLE OF THE PHARMACIST NINA BEMBEN, PHARMD MARY LYNN MCPHERSON, PAHRMD, MA, BCPS, CDE ZEMEN HABTEMARIAM, STUDENT PHARMACIST MANAGEMENT OF TYPE
More informationALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.
ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO
More informationPrescribing for Diabetes, England 2005-06 to 2012-13
Prescribing for Diabetes, England 2005-06 to 2012-13 Published 13 August 2013 This product is relevant to members of the public and other stakeholders to support the understanding of primary care prescribing
More informationDiabetes may be classified as. i) Type - I Diabetes mellitus. Type - II Diabetes mellitus. Type - 1.5 Diabetes mellitus. Gestational Diabetes INSULIN
HYPOGLYCEMIC AGENT Diabetes mellitus is a chronic metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting
More informationJANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets
JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets What is in this leaflet This leaflet answers some common questions about JANUVIA. It does not contain all the available information. It does
More informationCan one pill a day help lower your blood sugar?
See inside for valuable savings offer Can one pill a day help lower your blood sugar? What is FARXIGA? FARXIGA is a prescription medicine used along with diet and exercise to lower blood sugar in adults
More information